The American Cancer Society (ACS) has reaffirmed that average-risk adults should begin colorectal cancer screening at age 45 and continue through age 75, while incorporating newly approved stool-based and blood-based screening technologies into its updated guidance. The ACS continues to favor stool-based tests, including next-generation…
The U.S. healthcare system is approaching a tipping point, driven by three converging threats: rising care costs, a growing chronic…
In a bid to close persistent colorectal cancer (CRC) screening gaps, Guardant Health has launched a community grant program offering…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD) procedure, marking an expansion in advanced endoscopic capabilities.…
DDW 2026
A structured triage system for interventional GI referrals changed the originally requested…
DDW 2026 showcased several studies that may meaningfully influence upper GI clinical…
Thought Leadership
A structured triage system for interventional GI referrals changed the originally requested…
A growing disconnect is emerging between microbiome science and the booming consumer…
From supply chain management to billing practices, running a financially healthy gastroenterology…